These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 29052749)
1. [Body experience and self-esteem after minimally invasive skin rejuvenation : Study of female patients using botulinum toxin A and/or dermal fillers]. Scharschmidt D; Preiß S; Brähler E; Fischer T; Borkenhagen A Hautarzt; 2017 Dec; 68(12):959-967. PubMed ID: 29052749 [TBL] [Abstract][Full Text] [Related]
2. Topical skin therapies in subjects undergoing full facial rejuvenation. Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162 [TBL] [Abstract][Full Text] [Related]
3. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler. Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460 [TBL] [Abstract][Full Text] [Related]
4. Assessment of quality of life in patients who underwent minimally invasive cosmetic procedures. de Aquino MS; Haddad A; Ferreira LM Aesthetic Plast Surg; 2013 Jun; 37(3):497-503. PubMed ID: 23519872 [TBL] [Abstract][Full Text] [Related]
5. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044 [TBL] [Abstract][Full Text] [Related]
6. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers. Varga R Plast Surg Nurs; 2019; 39(4):119-124. PubMed ID: 31790040 [TBL] [Abstract][Full Text] [Related]
7. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers. Pao KY; Mancini R Curr Opin Ophthalmol; 2014 Sep; 25(5):461-9. PubMed ID: 24926573 [TBL] [Abstract][Full Text] [Related]
8. Body Image, Personality Traits, and Quality of Life in Botulinum Toxin A and Dermal Filler Patients. Scharschmidt D; Mirastschijski U; Preiss S; Brähler E; Fischer T; Borkenhagen A Aesthetic Plast Surg; 2018 Aug; 42(4):1119-1125. PubMed ID: 29948095 [TBL] [Abstract][Full Text] [Related]
9. Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers. Nanda S; Bansal S Indian J Dermatol Venereol Leprol; 2013; 79(1):32-40. PubMed ID: 23254727 [TBL] [Abstract][Full Text] [Related]
10. A Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments. Dayan SH; Ho TT; Bacos JT; Gandhi ND; Kalbag A; Gutierrez-Borst S J Drugs Dermatol; 2018 Jan; 17(1):48-54. PubMed ID: 29320587 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A and/or soft tissue fillers for facial rehabilitation. Wollina U; Goldman A Wien Med Wochenschr; 2017 Mar; 167(3-4):92-95. PubMed ID: 27631872 [TBL] [Abstract][Full Text] [Related]
12. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin. Beer KR; Julius H; Dunn M; Wilson F J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278 [TBL] [Abstract][Full Text] [Related]
13. The gold protocol: A combined treatment approach for neck rejuvenation with calcium hydroxyapatite, botulinum toxin, and hyaluronic acid in the same session. de Sanctis Pecora C J Cosmet Dermatol; 2024 Jul; 23(7):2392-2400. PubMed ID: 38566435 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem. Dayan SH; Arkins JP; Patel AB; Gal TJ Dermatol Surg; 2010 Dec; 36 Suppl 4():2088-97. PubMed ID: 21070456 [TBL] [Abstract][Full Text] [Related]
15. Injectable treatments for the aging face. Wise JB; Greco T Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805 [TBL] [Abstract][Full Text] [Related]
16. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. Carruthers J; Carruthers A; Monheit GD; Davis PG Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Effectiveness and Safety of a Botulinum Toxin Monotherapy and a Combination Therapy with Hyaluronic Acid Filler for Improving Glabellar Frown. Kim JH; Park ES; Nam SM; Choi CY Aesthetic Plast Surg; 2022 Aug; 46(4):1872-1880. PubMed ID: 35552477 [TBL] [Abstract][Full Text] [Related]
19. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations. Sundaram H; Liew S; Signorini M; Vieira Braz A; Fagien S; Swift A; De Boulle KL; Raspaldo H; Trindade de Almeida AR; Monheit G; Plast Reconstr Surg; 2016 May; 137(5):1410-1423. PubMed ID: 27119917 [TBL] [Abstract][Full Text] [Related]
20. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations. Carruthers JDA; Glogau RG; Blitzer A; Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]